AUA 2023

Prostate Cancer Hits Patients With Substantial Out-of-Pocket Expenses

Patients with localized prostate cancer may face substantial out-of-pocket expenses up to 24 months after diagnosis, a survey suggests.

Perioperative Outcomes of Cytoreductive Nephrectomy Improving in Metastatic RCC

Perioperative outcomes of cytoreductive nephrectomy for metastatic renal cell carcinoma improved from 2005 to 2019.

Prostate Cancer Diagnoses, Treatment Patterns Changed Due to COVID-19 Pandemic

Patients diagnosed with prostate cancer during the first year of the COVID-19 pandemic were more likely to have higher-risk disease and less likely to receive definitive treatment.

Adding ADT to MDT Improves Outcomes in Oligometastatic CSPC

Men with oligometastatic castration-sensitive prostate cancer have improved outcomes when ADT is added to MDT.

Locally Advanced, Low Metastatic Burden Prostate Cancer Have Similar Outcomes

Patients with locally advanced and low metastatic burden prostate cancer have similar oncologic outcomes when treated with ADT alone.

Cryoablation of T1a RCC Can Provide Long-Term Disease Control

Percutaneous cryoablation of localized T1a RCC provides long-term oncologic control with a low rate of complications, according to researchers.

Bladder Cancer Linked to Occupational Solvent Exposure

Occupational exposure to the solvents benzene, toluene, and zylene can increase the risk of bladder cancer, a new study suggests.

Black Men With Metastatic Prostate Cancer More Frequently Refuse Chemotherapy

A recent study revealed a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.